The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase I Study of Docetaxel (D) and Oxaliplatin (L-OHP) as Front-Line Treatment in Metastatic Breast Cancer (MBC) and Non-Small Cell Lung Cancer (NSCLC).
 
Takeshi Kawakami
No Relationships to Disclose
 
Hiroya Kashiwagi
No Relationships to Disclose
 
Keita Mori
No Relationships to Disclose
 
Katsuhiro Omae
No Relationships to Disclose
 
Jun Kasai
Employment - Taiho Pharmaceutical
 
Kunihiro Yoshisue
Employment - Taiho Pharmaceutical
 
Masahiro Kawahira
No Relationships to Disclose
 
Takahiro Tsushima
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Nozomu Machida
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - MSD
 
Akira Fukutomi
Honoraria - Daiichi Sankyo; Lilly Japan; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Yakult Honsha
Research Funding - NanoCarrier (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)
 
Ken Yamaguchi
No Relationships to Disclose
 
Hirofumi Yasui
No Relationships to Disclose